Policy

Medicare price negotiations, cancer care and ‘unintended consequences’
Medicare price negotiations, cancer care and ‘unintended consequences’
Lecia Bushak
January 13, 2022
12:40 pm

Some experts argue that the current Build Back Better pricing scheme will hinder cancer research and care.

More COVID, more CDC communications confusion
More COVID, more CDC communications confusion
Lecia Bushak
January 6, 2022
11:16 am

The CDC has tweaked its messaging to focus on harm reduction. It hasn’t made any difference.

‘Only mostly dead’? Build Back Better plan up in the air
‘Only mostly dead’? Build Back Better plan up in the air
Lecia Bushak
December 22, 2021
1:00 pm

The Build Back Better act’s drug-pricing reform scheme may be in jeopardy, but it’s not time to write an obituary just yet.

Telehealth key to ensuring access for people with addiction
Telehealth key to ensuring access for people with addiction
Lecia Bushak
December 16, 2021
3:09 pm

A just-released report suggests that states can and should act to maintain pandemic-era telehealth policies for addiction treatment.

“We’ve been waiting for something like this”
“We’ve been waiting for something like this”
Lecia Bushak
December 9, 2021
1:00 pm

Health and policy experts herald the Surgeon General’s acknowledgement of a “mental health crisis” among young people.

The Omicron messaging dilemma
The Omicron messaging dilemma
Lecia Bushak
December 3, 2021
5:10 am

Why public health experts believe communications around Omicron need to toe the line between too much concern and just enough.

The FDA’s upcoming clinical research revamp
The FDA’s upcoming clinical research revamp
Lecia Bushak
November 29, 2021
12:00 pm

Here’s what a restructuring of clinical trials might look like under FDA commissioner pick Dr. Robert Califf.

More vaccines, more vials, more raw materials
More vaccines, more vials, more raw materials
Lecia Bushak
November 18, 2021
10:58 am

The Biden administration’s initiative to boost manufacturing capacity launches with great ambitions and expectations.

Moderna, NIH dispute vaccine patent rights
Moderna, NIH dispute vaccine patent rights
Lecia Bushak
November 11, 2021
10:47 am

The dispute has potentially huge implications for the push to increase vaccine equity in poorer countries.

This time drug pricing reform is for real. Maybe.
This time drug pricing reform is for real. Maybe.
Lecia Bushak
November 3, 2021
3:58 pm

Will the iteration of reform agreed to by Congressional Democrats on Tuesday be the one that sticks?

  • From Our Partners